chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within seconds of Pfizer vac administration patient starts coughing and having bronchospasm with O2 sat initially between 89-95%. We immediately administered one dose=0.03 ml of epipen 1 mg/ml (lot # 33912, Exp 12/22) SC at 8:10 am. and patient condition improved significantly in a few minutes.  After the epipen her heart rate when up to 145 and BP when up to 134/84 but after a few minutes  both came down gradually until normal. We advised the patient to go on ambulance to hospital for observation. At 8:45 am she started shaking and coughing again and EMS administered Benadryl 25 mg  IM and We gave a 2nd dose= 0.03 ml SC  at 8:57 am of epipen 1 mg/ml. After the 2nd dose of Epipen Pt condition improved again. (cont)  At this time an ambulance was called by both the patient and EMT. The abulance called by EMT and therefore unable to have the patient handed off to them. The patient called an ambulance which was ACLS and therefore able to receive the patient. Patient's condition reported to Hospital and patient was sent in stable condition
Patient is 17yrs old and was administered Janssen (Johnson & Johnson) vaccine. No adverse reactions noted during time at clinic.
Moderna bivalent booster seemed to trigger shingles in the patient immediately with headaches commencing the day of the booster.  No other obvious stressors were present.  Dr. saw the patient on Sunday, 11/6/2022 after shingles blisters appeared on patient's forehead, eye lid, and eye ball.
gett shingle shut sshe gotta shingle; gotta shingle; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient got shingles shot and got shingles. This case was considered as suspected vaccination failure as details regarding vaccination schedule, time to onset for target disease and laboratory confirmation were unknown at the time of reporting. No further information was provided.
pt reports-red, swollen, warm area inner/medial aspect rt arm p/vax;areas extended from axilla-elbow-resolved spontaneously w/in 48hr w/o intervention;
From phone contact received at manufacturer on 5/31/02, it was reported by a health care prof'l that 4 y.o. male received Ipol, Infanrix, and MMR on 5/31/02 in the left thigh. PT developed an enlarged area at inject site. PT seen in ER and treated w/oral Prednisone. PT recovered. The PT had no known drug allergies at the time of vax. Responsible MD and PT info have been updated. No add'l info was provided. This case is closed.
I had a headache, extreme fatigue, achy joints and muscles. I had a scratchy throat also.
Fever, chills, headache, sinus pressure, tired, nausea, pain at injection sites. Start shortly after injection. Persist still at 24 hrs
patient felt lightheaded, dizzy, flush, sweating  -  after sitting and drinking some water over 20 minutes pt began to feel better
Janssen COVID-19 Vaccine EUA:  Adverse effects were nausea, vertigo, headache, body aches, chills, cold sweats for 6 days total.  Took Bonine for Vertigo and Nauzene for Nausea.
This spontaneous report was received from a doctor of pharmacy refers to a male patient of unknown age. On 11-DEC-2012, the patient was vaccinated with an expired dose of ZOSTAVAX, lot number reported as (671452/1124AA, expiry date: 12-OCT-2012, dose and route not reported). No concomitant medications were reported. No symptoms were reported. The patient had no complications and was not revaccinated. This is one of the three reports received from the same reporter. Additional information has been requested.
pt recvd vax 1APR94 & on 9APR94 had temp of 104; 10APR94 was hospitalized, had temp of 106; had approx 6-10 sz, rash all over body; dx w/UTI, ear infections, poss pneumonia, bronchitis; 15APR94 still poor appetite, wt loss but improving;
COVID 4 days afterwards; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID 4 days afterwards) in a 5-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced COVID-19 (COVID 4 days afterwards). At the time of the report, COVID-19 (COVID 4 days afterwards) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment drugs are not provided by reporter.
pt recd 2nd dose of MMR II & was dx w/mumps as serologically confirmed.
Information has been received from a nurse (also reported as healthcare worker with a degree of certified medical assistant) referring to a patient of unknown age and gender. On 29-APR-2010 the patient was vaccinated with the first dose of RECOMBIVAX HB (dose, route and lot # were not reported). The second, third and fourth dose was administered on 23-JUN-2010, 25-AUG-2010 and 25-OCT-2010, respectively. No adverse effects reported. Additional information has been requested.
CHILLS, FEVER 102, COUGH, HEADACHE, MUSCLE AND JOINT PAINT, FATIGUE, LARGE RASH UPPER LEFT ARM AT INJECTION SITE, ITCHY ON UPPER LEFT ARM.
Probable asymptomatic COVID-19 carriage following COVID-19 infection in late March early April, 2021 without evidence of pulmonary infiltrates or recent fevers.  does not require isolation for COVID-19, since the patient is likely chronically colonized and should not be contagious.
Patient presented to the emergency department at 8:45pm on 12/18/20 with lower abdominal pain, nausea, vomiting, and constipation that started approximately 2 hours prior to presentation, at approximately 6:45pm. Her labs were significant for a lipase of > 6000 IU/L, and a CT scan of her abdomen/pelvis was done that demonstrated evidence of acute pancreatitis. Given the fact that she does not have a history of heavy alcohol use, with normal triglycerides and no evidence of gallstones on her current admission, and no recent gastroenterology procedures, there is no clear etiology of her pancreatitis; concern for post-vaccination pancreatitis. The patient is currently admitted to the hospital, on hospital day #1 of her current condition.
Narrative: 74 y/o male received first dose of COVID-19 vaccination (Moderna) on 2/13/2021. Pt was hospitalized for cardiogenic shock and heart failure on 3/11 and signed AMA 3/16. Pt was admitted again to Hospital 3/20 and transferred to 3/21. Pt never received 2nd dose of COVID-19. Pt expired 3/31.
The morning following the vaccination, I woke up with a fever of 100.6, damp nightgown and sheets, very mild chills, some stomach bloating , and severe muscle aches and pains throughout my body. I was also so fatigued that I could do nothing all day except lay on the couch or in bed. I felt better that night around 8 PM. The injection site was also swollen, red and painful for about 5-6 days.  Today, it was itchy.
fatigue with on and off nose bleeds for 4 days (I can't remember the last time I had a nose bleed before this), then a week of symptoms consistent with pleurisy (sharp chest pain with breaths but not with shallow breaths and only comfortable to sleep on one side at night), then two days worth of lower back/side pain
Swollen upper arm (as if hard egg under skin), warm to touch; still sore as of today 10/27/11 but swelling has started to diminish.
Broke out in a rash on both arms legs and buttock around 3 in the afternoon after receiving shot at 730 am. Itchy, took ZYRTEC. No other symptoms. First reported to us Wed 10/11/17. Flu shots since 2012 without problems. 10/12 not much improvement, has to keep taking allergy pill to stop the itch. Trying CORTIZONE cream as well. 10/18/17 saw her Dr. He switched med to CLARITIN daily, ZANTAC, and BENADRYL at night. No creams. She states it's better but still some red bumps present.
Approximately 12 hours after shot (during the night), I woke up with debilitating pain in multiple parts of my body: wrists; left groin and leg; neck/shoulders; lower back and had a headache.   All of these areas were thrubbing and interrupted sleep.  Also was very weak.   Was difficult to get out of bed or a chair and to walk. Also had loss of appetite.  At no time, did I have a temperature.(Note:  I play tennis so was very active early in the week). The course of the symptoms has lasted 96hours but now seems to be subsiding. After 48 hours of inability to do any normal life activities, I contacted my physician who prescribed a cordtisone shot and anti-inflamatory medication, which I've taken for 2 days.
Chest pain, chest tightness as soon as 12 hours after the shot, went away for several hours, came back and lasted another 24 hours.  Extreme menstrual cramps, menstrual period came 3 days early, 36 hours the vaccine was administered. All other side effects went away after 48 hours and were listed as common side effects.
Information has been received from a consumer for GARDASIL, a Pregnancy Registry product, concerning his 33 year old wife with no allergy or drug reactions history, sickle cell anemia and headaches who on 14-SEP-2010, was vaccinated with her first and only dose of GARDASIL (route and lot number not reported). It was reported by the husband that other vaccines were given on the same day, but "he did not known the names of them". Urine pregnancy test was performed on the patient was pregnant LMP: 08NOV-2011, EDD: 15-AUG-2011. The reporter stated that on an unspecified date, his wife was experiencing "belly pain and headaches" and she went to the local ER and an ultrasound was performed. The results showed that the "baby was good, everything was good". His wife was not hospitalized and she received as recommendation a follow up with the obstetrician. At the time of the report the outcome of the patient was unknown. No further information is available.
no adverse event; Gave 2 doses of Moderna Covid-19 booster beyond 12 hrs; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave 2 doses of Moderna Covid-19 booster beyond 12 hrs) and NO ADVERSE EVENT (no adverse event) in a 59-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 042H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 07-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave 2 doses of Moderna Covid-19 booster beyond 12 hrs). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Gave 2 doses of Moderna Covid-19 booster beyond 12 hrs) and NO ADVERSE EVENT (no adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Gave 2 doses of Moderna Covid-19 booster beyond 12 hrs).    No concomitant medications were reported.   It was reported that the dose was drawn up in a syringe on 06-Feb-2023 and was administered on 07-Feb-2023.  No treatment details were reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-709074 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-709074:(same reporter)
This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills), NAUSEA (Severe nausea) and FATIGUE (very tired) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Codeine), Drug allergy (Lipitor), Drug allergy (Pravastatin), Drug allergy (Lorazepam), Drug allergy (Metronidazole), Allergy to antibiotic (Amoxicillin), Allergy to antibiotic (Ciprofloxacin), Drug allergy (Lopressor), Drug allergy (Edarbi), Drug allergy (Bystolic), Drug allergy (Sertaline Hcl), Drug allergy (Succinate ER) and Drug allergy (Spectrum active). Concomitant products included CLINDAMYCIN, ONDANSETRON, OMEPRAZOLE, ACETYLSALICYLIC ACID (ASPIRIN 81), AMLODIPINE, CARBIDOPA, LEVODOPA (LEVODOPA/CARBIDOPA), TESTOSTERONE and PARACETAMOL (TYLENOL) for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced HEADACHE (Headache) and CHILLS (Chills). On 05-May-2021, the patient experienced NAUSEA (Severe nausea) and FATIGUE (very tired). At the time of the report, HEADACHE (Headache), CHILLS (Chills), NAUSEA (Severe nausea) and FATIGUE (very tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment  Medications information included anti-nausea medication.   This case was linked to MOD-2021-237652 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: follow-up received on 5June2021 contain Patients demographic. 2.concomitant medications like Tylenol added and certain doses are updated.
My sister in law has vascular dementia.  She had no side effects at all following her first Pfizer vaccination.  Following the 2nd dose, she reported feeling physically fine the next day, however, family and caregivers witnessed mental status changes including inappropriate laughing, hysteria and screaming during the night following her dose, and weird behaviors the following day.  She is back to normal now but we wanted to report this in the event others with dementia have questions about side effects.
Received the injection at 11:15am 1/15/04. At approx. 1pm arm red, swollen and erythema from shoulder sore to elbow bullae at injection site. Benadryl 100mg-ce pack. Sent home.
Suspected vaccination failure; I have had vaccine and just recently broke out AGAIN; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The age group was reported but captured as adult as per vaccine indication. The reporter stated that the vaccine did not work for everyone that they would not get them again. The patient had the Shingles vaccine broke out again. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. The information regarding consent to follow up was not reported. This case has been linked with case US2021AMR089522, reported by the same reporter; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR089522:same reporter
Pt recvd 1st & 2nd dose p/2nd dose exp numb fingertips & couldn't raise arm above 90 degrees;
Delayed hypersensitivity left arm at vaccine site, rash, itching continued.  Note...lethargy, generalized pain started 16 hours after vaccine and lasted 48 hours
Information has been received from a licensed practical nurse concerning a 25 month old male child with "delayed immunization altered schedule" and no allergies who on 10-AUG-2009 was vaccinated subcutaneously with 0.5 ml of MMR II (lot # 664607/0609Y) in his right thigh.  There was no concomitant medication.  On 18-AUG-2009 the child was seen in the office and he had fever 37.22 on Temporal Thermometer, and red welt on right thigh.  No treatment.  The nurse stated no follow up visit with the child needed.  There were no laboratory studies performed.  At the time of report, the child had not recovered.  Follow up information was received from a Licensed Practical Nurse (L.P.N.) concerning the 25 month old (also reported as 27 month old) male child with no medical history or concurrent condition who on 10-AUG-2009 at 13:39 PM was vaccinated subcutaneously in the right thigh with the first dose of MMR II (lot # 664607/0609Y).  There was no concomitant medication.  There was no illness at the time of vaccination and adverse event following prior vaccination.  On 10-AUG-2009 the patient developed redness on right thigh and lasted for 8 days.  The patient also experienced fever for 2 days.  The patient recovered on unspecified date.  No relevant diagnostic tests or laboratory data was collected.  No further information is available.
Fever over 101 from 2pm on 12-31 until around 11am on 1/2, swollen armpit with pain to the underarm, shoulder, neck and back, fatigue. Rash also developed on thigh, not sure if that?s related. Fever is now gone but armpit is still swollen with arm and back pain. Rash mostly went down when fever did.
Red, warm area 3-4 inches in diameter.  Treatment Diphenhydramine 50 mg every 6 hours; Ibuprofen 400 mg every 4-6 hours; around pneumonia vaccination site.
The patient had just received her immunizations and PPD when she slumped over and lost consciousness.  Her body was stiff (particularly her arms) and she lost bladder.  She became alert after approximately 60 seconds and answered all questions appropriately but does have some amnesia surrounding the event.  We kept her in the office for an additional 30 minutes for monitoring.
Fatique 2 days (Saturday and Sunday following vaccine on Friday) but Monday had feelings described as "wierd", blurry vision, brain fog, eyes seemed to wander, super tired, eyes seemed to move back and forth, felt strange, disconnected, just not right.  These symptoms are continuing through today 4/14/21 - 5 days later.  When asked if better than yesterday she stated "Maybe a little"
syncope vs hypersomnolence occuring within 6 hours of vaccine administration. Happened at school. No direct witnesses. No neurologic sequelae on exam following day.
06/08/2021-Received  vaccine at Urgent Clinic. Pt found down at home. Brought to Hospital ED, with cardiac arrest (STEMI), where she later died.
tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced FATIGUE (tiredness). The patient was treated with PARACETAMOL (TYLENOL) for Tiredness, at an unspecified dose and frequency. At the time of the report, FATIGUE (tiredness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Patient reported that he received second dose of Pfizer and experienced adverse events.
sore arm; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 11Feb2021 (Batch/Lot Number: EL9266) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included unspecified statins. Patient previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 21Jan2021 (Lot Number: EL9262) as a single dose for COVID-19 immunization, and experienced tired/fatigued. It was reported that routine blood work (unknown results) was done on 18Feb2021 and added antibody test that showed results of negative antibodies. There was a plan on repeating the antibody test again in April. It was reported that patient is "not the only older patient that reporter has seen this in". Patient also experienced sore arm on an unspecified date in 2021 after second dose. Patient's primary doctor checks blood work every 3 months since she is on medications, they have to check her blood work to check her liver enzymes to see if they are elevated or not since she takes statins. The patient knew that when you get the vaccine, both times with Pfizer, you have to get Pfizer the first time and Pfizer the second time, same with the (company name). The patient's antibodies were showing negative, which the doctor has seen other patients who are elderly who have had negative antibodies too. When she had the blood work done it would have already been 3-4 weeks from the first dose. The patient's doctor was not sure why that is, he seemed to think that after the first dose there should be some sign but however he was saying, an article said it may take older people a little longer before there is an immunity against the virus from the vaccine. The patient didn't know if it should be from the time you take the second shot, or the time of the first shot. The patient said there's an article saying one dose of the vaccine should give you immunity. The patient wanted to know if she got the shot right. The patient was a nervous wreck because she knew she can't go get it again. Her mind was doing nothing but racing. The outcome of event was unknown.
A hemorrhage in the right eye; This spontaneous case was reported by a physician and describes the occurrence of EYE HAEMORRHAGE (A hemorrhage in the right eye) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN for an unknown indication.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EYE HAEMORRHAGE (A hemorrhage in the right eye). The patient was treated with CARBOMER (TEAR DROPS) at an unspecified dose and frequency. At the time of the report, EYE HAEMORRHAGE (A hemorrhage in the right eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment include hydration.  Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
I had a really bad headache after the vaccine. Blood pressure went up my hands started shaking and my face. Fatigues for 2 x day. Blood sugar level was between 400-500. Appointment scheduled for Friday to measure blood sugar and follow up with medications.